Avidity Historical Financial Ratios

RNA Stock

USD 43.33 0.47 1.07%

Avidity Biosciences is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 5.01, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 4.2 will help investors to properly organize and evaluate Avidity Biosciences financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.

About Avidity Financial Ratios Analysis

Avidity BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Avidity Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Avidity financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Avidity Biosciences history.

Avidity Biosciences Financial Ratios Chart

At present, Avidity Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 4.20, whereas Price To Sales Ratio is forecasted to decline to 65.66.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Ev To Sales Price Earnings Ratio

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Avidity Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Avidity Biosciences sales, a figure that is much harder to manipulate than other Avidity Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Avidity Biosciences dividend as a percentage of Avidity Biosciences stock price. Avidity Biosciences dividend yield is a measure of Avidity Biosciences stock productivity, which can be interpreted as interest rate earned on an Avidity Biosciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Avidity Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Avidity Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.At present, Avidity Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 4.20, whereas Price To Sales Ratio is forecasted to decline to 65.66.

	2023	2024 (projected)
Dividend Yield	8.9E-5	7.9E-5
Price To Sales Ratio	69.12	65.66

Dividend Yield Price To Sales Ratio

Avidity Biosciences fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		0.49	-0.89	0.72	-0.87	0.8	0.8	-0.79	-0.89	1.0	0.81	0.9	-0.78	0.92	0.35	0.77	0.64	-0.77	-0.9	-0.4	0.91	-0.5	0.22	-0.38	-0.78	0.48
Dividend Yield	0.49		-0.5	0.28	-0.25	0.78	0.35	-0.19	-0.5	0.48	0.35	0.65	-0.61	0.57	-0.1	0.61	-0.18	-0.74	-0.23	-0.02	0.57	-0.8	0.33	-0.01	-0.66	0.33
Ptb Ratio	-0.89	-0.5		-0.8	0.95	-0.89	-0.96	0.84	1.0	-0.89	-0.96	-0.97	0.85	-0.97	-0.41	-0.89	-0.71	0.86	0.93	-0.05	-0.99	0.5	-0.62	-0.07	0.85	-0.06
Days Sales Outstanding	0.72	0.28	-0.8		-0.7	0.77	0.87	-0.76	-0.8	0.72	0.87	0.82	-0.93	0.87	0.56	0.92	0.51	-0.83	-0.69	-0.01	0.79	-0.43	0.46	0.0	-0.89	0.09
Book Value Per Share	-0.87	-0.25	0.95	-0.7		-0.72	-0.92	0.82	0.95	-0.87	-0.92	-0.86	0.67	-0.87	-0.37	-0.71	-0.88	0.65	0.99	0.02	-0.92	0.3	-0.51	0.0	0.65	-0.04
Free Cash Flow Yield	0.8	0.78	-0.89	0.77	-0.72		0.82	-0.61	-0.89	0.8	0.82	0.97	-0.92	0.93	0.21	0.94	0.33	-0.96	-0.69	0.06	0.93	-0.8	0.59	0.07	-0.93	0.18
Operating Cash Flow Per Share	0.8	0.35	-0.96	0.87	-0.92	0.82		-0.82	-0.96	0.8	1.0	0.91	-0.86	0.94	0.46	0.89	0.76	-0.8	-0.89	0.15	0.93	-0.34	0.66	0.17	-0.83	-0.09
Capex To Depreciation	-0.79	-0.19	0.84	-0.76	0.82	-0.61	-0.82		0.84	-0.79	-0.82	-0.77	0.7	-0.78	-0.82	-0.72	-0.77	0.7	0.86	0.09	-0.8	0.2	-0.44	0.08	0.73	-0.09
Pb Ratio	-0.89	-0.5	1.0	-0.8	0.95	-0.89	-0.96	0.84		-0.89	-0.96	-0.97	0.85	-0.97	-0.41	-0.89	-0.71	0.86	0.93	-0.05	-0.99	0.5	-0.62	-0.07	0.85	-0.06
Ev To Sales	1.0	0.48	-0.89	0.72	-0.87	0.8	0.8	-0.79	-0.89		0.8	0.9	-0.78	0.92	0.35	0.77	0.64	-0.77	-0.9	-0.4	0.9	-0.49	0.21	-0.39	-0.77	0.49
Free Cash Flow Per Share	0.81	0.35	-0.96	0.87	-0.92	0.82	1.0	-0.82	-0.96	0.8		0.91	-0.86	0.94	0.47	0.9	0.76	-0.81	-0.89	0.15	0.93	-0.35	0.66	0.16	-0.83	-0.08
Roic	0.9	0.65	-0.97	0.82	-0.86	0.97	0.91	-0.77	-0.97	0.9	0.91		-0.92	0.98	0.35	0.94	0.55	-0.94	-0.85	-0.01	0.99	-0.66	0.58	0.01	-0.92	0.18
Inventory Turnover	-0.78	-0.61	0.85	-0.93	0.67	-0.92	-0.86	0.7	0.85	-0.78	-0.86	-0.92		-0.94	-0.44	-0.99	-0.37	0.97	0.66	0.02	-0.87	0.62	-0.5	0.0	0.99	-0.19
Net Income Per Share	0.92	0.57	-0.97	0.87	-0.87	0.93	0.94	-0.78	-0.97	0.92	0.94	0.98	-0.94		0.38	0.95	0.6	-0.91	-0.86	-0.08	0.97	-0.57	0.5	-0.06	-0.92	0.22
Days Of Inventory On Hand	0.35	-0.1	-0.41	0.56	-0.37	0.21	0.46	-0.82	-0.41	0.35	0.47	0.35	-0.44	0.38		0.44	0.48	-0.42	-0.42	0.0	0.36	0.1	0.29	0.0	-0.48	-0.07
Payables Turnover	0.77	0.61	-0.89	0.92	-0.71	0.94	0.89	-0.72	-0.89	0.77	0.9	0.94	-0.99	0.95	0.44		0.42	-0.97	-0.69	0.08	0.9	-0.62	0.6	0.1	-0.99	0.1
Average Inventory	0.64	-0.18	-0.71	0.51	-0.88	0.33	0.76	-0.77	-0.71	0.64	0.76	0.55	-0.37	0.6	0.48	0.42		-0.29	-0.89	0.0	0.64	0.18	0.37	0.01	-0.33	-0.14
Capex To Revenue	-0.77	-0.74	0.86	-0.83	0.65	-0.96	-0.8	0.7	0.86	-0.77	-0.81	-0.94	0.97	-0.91	-0.42	-0.97	-0.29		0.64	-0.04	-0.88	0.74	-0.57	-0.05	0.99	-0.18
Cash Per Share	-0.9	-0.23	0.93	-0.69	0.99	-0.69	-0.89	0.86	0.93	-0.9	-0.89	-0.85	0.66	-0.86	-0.42	-0.69	-0.89	0.64		0.12	-0.91	0.27	-0.43	0.1	0.64	-0.12
Pocfratio	-0.4	-0.02	-0.05	-0.01	0.02	0.06	0.15	0.09	-0.05	-0.4	0.15	-0.01	0.02	-0.08	0.0	0.08	0.0	-0.04	0.12		0.02	0.02	0.8	1.0	0.01	-0.95
Interest Coverage	0.91	0.57	-0.99	0.79	-0.92	0.93	0.93	-0.8	-0.99	0.9	0.93	0.99	-0.87	0.97	0.36	0.9	0.64	-0.88	-0.91	0.02		-0.59	0.6	0.03	-0.86	0.12
Payout Ratio	-0.5	-0.8	0.5	-0.43	0.3	-0.8	-0.34	0.2	0.5	-0.49	-0.35	-0.66	0.62	-0.57	0.1	-0.62	0.18	0.74	0.27	0.02	-0.59		-0.34	0.01	0.66	-0.3
Capex To Operating Cash Flow	0.22	0.33	-0.62	0.46	-0.51	0.59	0.66	-0.44	-0.62	0.21	0.66	0.58	-0.5	0.5	0.29	0.6	0.37	-0.57	-0.43	0.8	0.6	-0.34		0.81	-0.52	-0.68
Pfcf Ratio	-0.38	-0.01	-0.07	0.0	0.0	0.07	0.17	0.08	-0.07	-0.39	0.16	0.01	0.0	-0.06	0.0	0.1	0.01	-0.05	0.1	1.0	0.03	0.01	0.81		0.0	-0.94
Days Payables Outstanding	-0.78	-0.66	0.85	-0.89	0.65	-0.93	-0.83	0.73	0.85	-0.77	-0.83	-0.92	0.99	-0.92	-0.48	-0.99	-0.33	0.99	0.64	0.01	-0.86	0.66	-0.52	0.0		-0.2
Income Quality	0.48	0.33	-0.06	0.09	-0.04	0.18	-0.09	-0.09	-0.06	0.49	-0.08	0.18	-0.19	0.22	-0.07	0.1	-0.14	-0.18	-0.12	-0.95	0.12	-0.3	-0.68	-0.94	-0.2

Click cells to compare fundamentals

Avidity Biosciences Account Relationship Matchups

Avidity Biosciences fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	461.0	81.46	105.59	125.49	69.12	65.66
Ptb Ratio	(16.36)	1.81	2.58	2.0	1.32	1.39
Book Value Per Share	(1.74)	14.14	9.21	11.08	6.86	5.01
Free Cash Flow Yield	0.002109	(0.0691)	(0.1)	(0.12)	(0.19)	(0.18)
Stock Based Compensation To Revenue	0.18	0.64	1.83	2.94	4.0	4.2
Capex To Depreciation	0.68	2.93	5.85	2.04	2.01	1.82
Pb Ratio	(16.36)	1.81	2.58	2.0	1.32	1.39
Ev To Sales	422.34	33.25	63.17	89.74	50.79	48.25
Free Cash Flow Per Share	0.0601	(1.76)	(2.38)	(2.67)	(1.69)	(1.77)
Net Income Per Share	(0.86)	(2.03)	(2.83)	(3.24)	(2.91)	(3.05)
Sales General And Administrative To Revenue	2.2	1.98	2.81	4.09	5.67	3.1
Research And Ddevelopement To Revenue	6.27	5.54	10.85	16.31	19.98	10.82
Capex To Revenue	0.1	0.16	0.4	0.31	0.44	0.46
Cash Per Share	2.52	15.46	11.84	11.71	8.15	6.65
Pocfratio	429.34	(14.89)	(10.39)	(8.49)	(5.55)	(5.27)
Capex To Operating Cash Flow	0.0944	(0.0294)	(0.0394)	(0.0207)	(0.0355)	(0.0337)
Pfcf Ratio	474.08	(14.47)	(9.99)	(8.32)	(5.36)	(5.09)
Days Payables Outstanding	57.94	75.18	1.6K	1.2K	1.5K	1.6K
Income Quality	(0.1)	0.84	0.8	0.78	0.56	0.5
Roe	0.49	(0.14)	(0.31)	(0.29)	(0.42)	(0.4)
Ev To Operating Cash Flow	393.34	(6.08)	(6.21)	(6.07)	(4.08)	(3.87)
Pe Ratio	(33.28)	(12.57)	(8.39)	(6.85)	(3.11)	(3.27)
Return On Tangible Assets	(0.33)	(0.13)	(0.27)	(0.26)	(0.34)	(0.35)
Ev To Free Cash Flow	434.33	(5.91)	(5.98)	(5.95)	(3.94)	(3.74)
Earnings Yield	(0.03)	(0.0796)	(0.12)	(0.15)	(0.32)	(0.31)
Net Debt To E B I T D A	5.35	7.47	3.37	1.86	0.75	0.71
Current Ratio	9.35	22.74	13.86	12.0	7.58	8.83
Tangible Book Value Per Share	(1.74)	14.14	9.21	11.08	6.86	5.01
Graham Number	5.79	25.41	24.23	28.43	21.18	14.68
Shareholders Equity Per Share	(1.74)	14.14	9.21	11.08	6.86	5.01
Debt To Equity	(0.0695)	0.003063	0.0308	0.0185	0.0197	0.0207
Capex Per Share	0.006265	0.0504	0.0903	0.0541	0.0579	0.0349
Graham Net Net	(1.8)	14.19	10.73	10.54	6.4	5.07
Revenue Per Share	0.0618	0.31	0.23	0.18	0.13	0.12

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:

How To Invest In Avidity

Details

Is Avidity Stock a good investment?

Details

What is Avidity Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.88)

Revenue Per Share

0.103

Quarterly Revenue Growth

(0.17)

Return On Assets

(0.18)

Return On Equity

(0.28)

The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avidity Historical Financial Ratios

About Avidity Financial Ratios Analysis

Avidity Biosciences Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ev To Sales

Avidity Biosciences fundamentals Correlations

Avidity Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avidity Biosciences fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Cash Per Share	+ 0.99	Book Value Per Share
Interest Coverage	+ 0.99	Roic

Days Payables Outstanding	- 0.99	Payables Turnover
Payables Turnover	- 0.99	Inventory Turnover
Interest Coverage	- 0.99	Pb Ratio
Interest Coverage	- 0.99	Ptb Ratio
Capex To Revenue	- 0.97	Payables Turnover
Net Income Per Share	- 0.97	Pb Ratio